ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $58 | -40.8% | 36,699 | +133.0% | 0.01% | -50.0% |
| Q4 2022 | $98 | -99.9% | 15,753 | +1.0% | 0.01% | +25.0% |
| Q1 2022 | $72,000 | -13.3% | 15,598 | -5.9% | 0.01% | -11.1% |
| Q4 2021 | $83,000 | -79.2% | 16,570 | +93.1% | 0.01% | -86.6% |
| Q2 2019 | $399,000 | +21.3% | 8,580 | +4.8% | 0.07% | +24.1% |
| Q1 2019 | $329,000 | -53.5% | 8,190 | -42.0% | 0.05% | -53.0% |
| Q3 2017 | $707,000 | – | 14,110 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |